Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Zealand Pharma - Filing #1417063

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
14,155,000 DKK
8,977,000 DKK
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
346,033,000 DKK
342,261,000 DKK
Current assets
1,721,596,000 DKK
1,419,688,000 DKK
Non-current liabilities
805,509,000 DKK
177,378,000 DKK
Current liabilities
334,317,000 DKK
355,260,000 DKK
Revenue
292,567,000 DKK
353,314,000 DKK
41,333,000 DKK
Profit (loss)
0 DKK
0 DKK
0 DKK
0 DKK
1,018,149,000 DKK
1,018,149,000 DKK
846,729,000 DKK
0 DKK
846,729,000 DKK
0 DKK
0 DKK
0 DKK
0 DKK
571,541,000 DKK
571,541,000 DKK
0 DKK
0 DKK
0 DKK
Other comprehensive income
0 DKK
0 DKK
5,178,000 DKK
0 DKK
5,178,000 DKK
0 DKK
8,977,000 DKK
0 DKK
0 DKK
0 DKK
8,977,000 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
0 DKK
Comprehensive income
1,012,972,000 DKK
837,752,000 DKK
571,541,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.